Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2Phase 3 Interventional Results available

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

ClinicalTrials.gov ID: NCT03706365

Public ClinicalTrials.gov record NCT03706365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 12:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednisone per local regulation.

Study identification

NCT ID
NCT03706365
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
393 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2018 (Actual)
Primary completion
Jan 2, 2024 (Actual)
Completion
Dec 2026 (Estimated)
Last update posted
Aug 7, 2026

2018 – 2026

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
St. Joseph's Hospital and Medical Center Phoenix Arizona 85004 —
Mayo Clinic in Arizona - Phoenix Phoenix Arizona 85054 —
The University of Arizona Cancer Center - North Campus Tucson Arizona 85719 —
St. Bernards Medical Center Jonesboro Arkansas 72401 —
CBCC Global Research, Inc. Bakersfield California 93309 —
Providence St. Jude Medical Center Fullerton California 92835 —
Moores Cancer Center La Jolla California 92093 —
TRIO-US (Translational Research in Oncology-US) Los Angeles California 90024 —
UCLA Hematology/Oncology - Westwood (Building 100) Los Angeles California 90095 —
Pacific Cancer Care Monterey California 93940 —
Sansum Clinic_Kendle Santa Barbara California 93105 —
Rocky Mountain Cancer Center Lone Tree Colorado 80124 —
Millennium Oncology - Hollywood Hollywood Florida 33024 —
Northside Hospital Atlanta Georgia 30342 —
Fort Wayne Medical Oncology And Hematology at Parkview Comprehensive Cancer Center Fort Wayne Indiana 46804 —
Massachusetts General Hospital Boston Massachusetts 02114 —
M Health Fairview University of Minnesota Medical Center - East Bank Minneapolis Minnesota 55455 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89119 —
New York Oncology Hematology (NYOH) - Clifton Park Cancer Center Albany New York 12206 —
Associated Medical Professionals - Urology Syracuse New York 13210 —
Research Medical Center Nashville Tennessee 37203 —
Baylor Scott & White Medical Center - Temple Temple Texas 76508 —
New York Oncology Hematology (NYOH) - Clifton Park Cancer Center The Woodlands Texas 77380 —
Northwest Cancer Specialists PC The Woodlands Texas 77380 —
Sansum Clinic_Kendle The Woodlands Texas 77380 —
Texas Oncology - Longview Cancer Center The Woodlands Texas 77380 —
Texas Oncology Cancer Care and Research Center The Woodlands Texas 77380 —
Texas Oncology Fort Worth The Woodlands Texas 77380 —
Texas Oncology-Memorial City The Woodlands Texas 77380 —
US Oncology The Woodlands Texas 77380 —
USO-Cancer Care Center of Brevard, Inc. The Woodlands Texas 77380 —
Huntsman Cancer Institute Salt Lake City Utah 84112 —
The University of Vermont Medical Center Inc. Burlington Vermont 05405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03706365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2026 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03706365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →